# Evaluation of ReX-C System in Measurement and Improvement of Patients' Adherence.

> **NCT03424330** · NA · UNKNOWN · sponsor: **Dosentrx Ltd.** · enrollment: 100 (estimated)

## Conditions studied

- Thromboembolism

## Interventions

- **DEVICE:** ReX-C intervention
- **OTHER:** Standard of Care

## Key facts

- **NCT ID:** NCT03424330
- **Lead sponsor:** Dosentrx Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01-09
- **Primary completion:** 2023-12-25
- **Final completion:** 2023-12-25
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03424330

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03424330, "Evaluation of ReX-C System in Measurement and Improvement of Patients' Adherence.". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03424330. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*